Literature DB >> 156215

Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man.

E L Reinherz, S F Schlossman.   

Abstract

Human peripheral lymphoid cells pretreated with Concanavalin A for 48 hr can markedly suppress the proliferative response of untreated autologous lymphoid cells in MLC. Isolation studies with Sephadex G-200 anti-F(ab')2 affinity chromatography, nylon adherence, and E rosetting indicate that the Con A-induced suppressor cell is a T cell. Further fractionation into TH2+ and TH2- cell subsets with an equine-anti TH2 serum show that both subsets can be activated by Con A to an equivalent degree. After activation only the TH2+ subset can suppress autologous responder cells in MLC. The TH2- subset, which comprises 80% of peripheral human T cells, although induced by Con A to proliferate, cannot itself suppress the MLC response. Nevertheless, the TH2- subset can be shown to modulate the generation of suppressor TH2+ cells at 24 hr but not at 48 hr. These studies support the notion that the Con A-induced suppressor cell is confined to a distinct T cell subset in man and that T-T interactions are important in the overall expression of the immune response.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156215

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

Review 2.  Human T-cell subsets in health and disease.

Authors:  S F Schlossman; E L Reinherz
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).

Authors:  S Tomino; H Fujiwara; T Kagimoto; H Mitsuya; H Nishimura; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

4.  T cell chronic lymphocytic leukaemia with suppressor phenotype.

Authors:  F M Hofman; D Smith; W Hocking
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

5.  Monoclonal antibody investigation in rheumatoid arthritis: presence of a T cell subpopulation bearing a double marker.

Authors:  G Lapadula; M Covelli; R Numo; G Tricarico; G Amendoni; C Berlingerio
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Subset derivation of T-cell acute lymphoblastic leukemia in man.

Authors:  E L Reinherz; L M Nadler; S E Sallan; S F Schlossman
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  Autoimmune blood dyscrasias in five patients with hypogammaglobulinemia: response of neutropenia to vincristine.

Authors:  A D Webster; T A Platts-Mills; G Jannossy; M Morgan; G L Asherson
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

8.  Effect of histamine on the mitogenic response of human lymphocytes and its modification by cimetidine and levamisole.

Authors:  K Meretey; G Room; R N Maini
Journal:  Agents Actions       Date:  1981-04

9.  Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.

Authors:  C D Platsoucas; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy.

Authors:  A Durandy; A Fischer; C Griscelli
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.